Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer oleh David Fogelman, Antonio Cubillo, Pilar García‐Alfonso, María Luisa Limón Mirón, John Nemunaitis, Daniel Flora, Christophe Borg, Laurent Mineur, Jose M. Vieitez, Allen Cohn, Gene Saylors, Albert Assad, Julie Switzky, Li Zhou, Johanna Bendell